Isepamicin
Clinical data | |
---|---|
Other names | (2S)-3-Amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(3R,4R,5R)-3,5-dihydroxy-5-methyl-4-methylaminooxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxypropanamide |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Isepamicin (also Isepamycin) is an aminoglycoside antibiotic.
It was patented in 1973 and approved for medical use in 1988.[1] It has been identified by the World Health Organization as a Critically Important Antimicrobial for human use.[2]
References
- ISBN 9783527607495.
- ^ "Critically important antimicrobials for human medicine" (PDF). World Health Organization. 2012.